• Cryptomonnaies
  • Marchés de Prédiction
  • Actualités
  • Trading Agentique
  • Articles
  • Ligues

Rechercher des Cryptomonnaies

Cryptomonnaies en tendance

CoinRithm

Entreprise

Entité légale
Bees-x Limited
Numéro de société
13308136
Constituée en
England and Wales
Siège social
Monmouth House, High Street, Watford, England, WD17 1LN

CoinRithm est un service d'information et de recherche exploité par Bees-x Limited. Il n'est pas autorisé par la Financial Conduct Authority (FCA) à exercer des activités réglementées, et rien sur ce site ne constitue un conseil financier.

Explorer

CryptomonnaiesMarchés de PrédictionActualitésArticlesAgent ArenaLigues

Fonctionnalités

Tableau de bordÉchange FictifTrading AgentiquePortefeuilleListe de suiviParamètres

Entreprise

À Propos de NousMethodologieConditions d'utilisationPolitique de ConfidentialitéPolitique en Matière de CookiesAvertissement

Support

Contactez le SupportFAQKit développeurDocs MCP

Réseaux

X (Twitter)FacebookLinkedInTelegramInstagramTikTokYouTube
© 2026 CoinRithm. Tous droits réservés.
Disponible sur Google PlayTélécharger sur l'App Store
  • Accueil
  • MarchésMarchés de Prédiction
  • Actualités
  • Tableau de bord
  1. Marchés de Prédiction
  2. Health & Medicine
  3. When will Compass Pathways submit a NDA for COMP360 psilocybin?
When will Compass Pathways submit a NDA for COMP360 psilocybin?

When will Compass Pathways submit a NDA for COMP360 psilocybin?

1.0% (24h)Health & MedicineOne-OffScienceBusiness & Corporate2mo
KalshiKalshiVérifier la disponibilitéKYC requis2% de frais
Probabilité implicite actuelle
before September
before September 31%+1.0%
En tête parmi 6 options
Qualite du marche

28 / 100

Faible qualité
Volume 24h

0,3 €

Liquidité

38,2 €

Faible liquidité
Achat / Vente

22.0% / 31.0%

Spread

40.9%

Spread large
Données du marché

Mis à jour il y a 3 minutes

24 mars 26, 14:001 sept. 26, 14:00

Tendances

Résultat24hProbabilité

Résultat choisi

before September31%

Règles

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.

Marchés Associés

When will Beam Therapeutics submit a BLA for Risto-cel?

When will Beam Therapeutics submit a BLA for Risto-cel?

0,3 €
before April 2027: 72%KalshiKALSHI
Will there be a year without polio before 2030?

Will there be a year without polio before 2030?

0 €
Oui: 10%KalshiKALSHI
When will Intellia Therapeutics submit a BLA for Lonvo-z?

When will Intellia Therapeutics submit a BLA for Lonvo-z?

0 €
before September: 45%KalshiKALSHI
Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

108,8 €
Uganda: 100%PolymarketPOLYMARKET
US fertility rate up in Q1 2026?

US fertility rate up in Q1 2026?

0 €
Oui: 36%PolymarketPOLYMARKET
Which geographical areas will Tomorrow Bio cover at the end of 2026?

Which geographical areas will Tomorrow Bio cover at the end of 2026?

1,1 k €
🇨🇦 Canada: 23.9%Manifold MarketsMANIFOLD MARKETS

Actifs dans ces sujets

BitcoinBTC$62,682.54+2.38%EthereumETH$1,651.16+1.73%SolanaSOL$65.16+1.80%DogecoinDOGE$0.0851+1.95%XRPXRP$1.12+0.49%BNBBNB$595.34+1.77%

Actualités Associées

JPMorgan plans longer-running AI agents for corporate workflows Crypto NewsA16z, Paradigm lead $175 million bet to move global credit markets onchainCoindeskMorpho raises $175M at $2B valuation for institutional DeFi pushCrypto NewsAmazon signs Corning fiber deal to expand U.S. data centersCrypto NewsSpaceX Price Prediction: Will IPO Hype Justify a Multi-Trillion Dollar Valuation?Blockchain ReporterA massive hiring wave reveals trading firms are no longer viewing Polymarket as a niche betting toolCoindesk

Règles

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.